Marker Therapeutics, Inc.
MRKR· Nasdaq
MRKRMarker Therapeutics, Inc.
Filed Aug 19, 2013 · 10-Q · 50 days after period end · 0001424884-13-000038
| Metric | Q2 2013 | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|---|
| Net Income | -$870.81K | -$2.54M | -$404.38K | -$1.34M |
| EPS Diluted | -$0.87 | -$0.04 | -$0.01 | -$0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Marker Therapeutics, Inc. · CIK 1094038 · Engraved from SEC EDGAR
ended Jun 30, 2013 · filed Aug 19, 2013 · 50 d after period end
